Related Experiment Video

Updated: Jul 16, 2026

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells

Yucel Ustundag1, Steven F Bronk, Gregory J Gores

  • 1Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota 55905, USA.

World Journal of Gastroenterology
|March 14, 2007
PubMed
Abstract

Insights

Proteasome inhibition triggers endoplasmic reticulum dysfunction and caspase-independent cell death in human cholangiocarcinoma cells. These findings suggest proteasome inhibitors may be effective anticancer agents for cholangiocarcinoma treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Cholangiocarcinoma is a challenging cancer with limited treatment options.
  • Proteasome inhibitors are emerging as potential anti-cancer therapeutics.

Purpose of the Study:

  • To investigate the effect of proteasome inhibition on human cholangiocarcinoma cells.
  • To elucidate the underlying cellular mechanisms of proteasome inhibitor-induced cell death.

Main Methods:

  • Human cholangiocarcinoma cell lines (KMCH, KMBC, Mz-ChA-1) and normal rat cholangiocytes were treated with MG132 (proteasome inhibitor).
  • Apoptosis was assessed via DAPI staining, mitochondrial membrane potential assays, transmission electron microscopy (TEM), and caspase activity assays.
  • Endoplasmic reticulum (ER) stress and protein synthesis were evaluated.

Main Results:

  • MG132 induced apoptosis in cholangiocarcinoma cells but not normal cells, in a time- and concentration-dependent manner.
  • TEM revealed apoptotic features and significant ER vacuolization.
  • Caspase 3/7 activity did not increase, and cell death was not prevented by a pancaspase inhibitor, indicating a caspase-independent pathway.
  • Protein synthesis inhibition blocked MG132-induced apoptosis, suggesting ER dysfunction is protein synthesis-dependent.

Conclusions:

  • Proteasome inhibition selectively induces ER dysfunction and caspase-independent cell death in human cholangiocarcinoma.
  • Proteasome inhibitors show promise as a therapeutic strategy for cholangiocarcinoma.

More Related Videos

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...